Please assess the completion status of the following clinical trial:

Trial Title: A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects with diagnosis of Ulcerative Colitis for 3 or more months.~* Ulcerative colitis must be active beyond the rectum.~* Must active Ulcerative Colitis with a Total Mayo Score of 6 to 12 points~Exclusion Criteria:~* Pregnant or breast feeding.~* Diagnosis of indeterminate colitis or Crohn's Disease~* Subjects with history of colonic or small bowel obstruction or resection.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- Drug Dose Level 1 (Type: EXPERIMENTAL): None
- Drug Dose Level 2 (Type: EXPERIMENTAL): None
- Drug Dose Level 3 (Type: EXPERIMENTAL): None
- Drug Dose Level 4 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).